Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene.
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads.
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
[Resistance to protease inhibitors].